JAMA Surg 158(10):10031011 Miras AD et al (2019) Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial
Day 2 at AAO is off to a flying start
They will continue to help you feel more in control
If you're considering a probiotic, choose carefully
May your protein stay plentiful, your muscles stay strong, and your semaglutide results stay transformative.
Acknowledgements The authors wish to acknowledge Humphrey Chukwudi Omeoga, of Thomas BegLey Laboratory, Department of Biological Sciences, State University of New York, at Albany, New York USA for using his licensed accessed BioRender for the diagrams sketching